These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 39392391)
21. Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses. Riedl A; Schlederer M; Pudelko K; Stadler M; Walter S; Unterleuthner D; Unger C; Kramer N; Hengstschläger M; Kenner L; Pfeiffer D; Krupitza G; Dolznig H J Cell Sci; 2017 Jan; 130(1):203-218. PubMed ID: 27663511 [TBL] [Abstract][Full Text] [Related]
22. Prognostic significance and value of further classification of lymphovascular invasion in invasive breast cancer: a retrospective observational study. Zhang Y; Wang H; Zhao H; He X; Wang Y; Wang H Breast Cancer Res Treat; 2024 Jul; 206(2):397-410. PubMed ID: 38771398 [TBL] [Abstract][Full Text] [Related]
23. Role of E-cadherins in development of lymphatic tumor emboli. Gupta A; Deshpande CG; Badve S Cancer; 2003 May; 97(9):2341-7. PubMed ID: 12712492 [TBL] [Abstract][Full Text] [Related]
24. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps. Na TY; Schecterson L; Mendonsa AM; Gumbiner BM Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5931-5937. PubMed ID: 32127478 [TBL] [Abstract][Full Text] [Related]
26. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast. Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627 [TBL] [Abstract][Full Text] [Related]
27. Bone Metastasis: Molecular Mechanisms Implicated in Tumour Cell Dormancy in Breast and Prostate Cancer. Quayle L; Ottewell PD; Holen I Curr Cancer Drug Targets; 2015; 15(6):469-80. PubMed ID: 25968899 [TBL] [Abstract][Full Text] [Related]
28. A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway. Wang S; Zhang Y; Ren T; Wu Q; Lu H; Qin X; Liu Y; Ding H; Zhao Q Cell Death Dis; 2020 Jun; 11(6):491. PubMed ID: 32606352 [TBL] [Abstract][Full Text] [Related]
29. Hypericum roeperianum bark extract suppresses breast cancer proliferation via induction of apoptosis, downregulation of PI3K/Akt/mTOR signaling cascade and reversal of EMT. Guefack MF; Talukdar D; Mukherjee R; Guha S; Mitra D; Saha D; Das G; Damen F; Kuete V; Murmu N J Ethnopharmacol; 2024 Jan; 319(Pt 1):117093. PubMed ID: 37634746 [TBL] [Abstract][Full Text] [Related]
30. A novel human xenograft model of inflammatory breast cancer. Alpaugh ML; Tomlinson JS; Shao ZM; Barsky SH Cancer Res; 1999 Oct; 59(20):5079-84. PubMed ID: 10537277 [TBL] [Abstract][Full Text] [Related]
31. D2-40 in breast cancer: should we detect more vascular emboli? de Mascarel I; MacGrogan G; Debled M; Sierankowski G; Brouste V; Mathoulin-Pélissier S; Mauriac L Mod Pathol; 2009 Feb; 22(2):216-22. PubMed ID: 18820667 [TBL] [Abstract][Full Text] [Related]
32. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer. Schoppmann SF; Tamandl D; Roberts L; Jomrich G; Schoppmann A; Zwrtek R; Dubsky P; Gnant M; Jakesz R; Birner P Ann Oncol; 2010 May; 21(5):955-60. PubMed ID: 19940005 [TBL] [Abstract][Full Text] [Related]
33. Phenotypic Heterogeneity and Metastasis of Breast Cancer Cells. Hapach LA; Carey SP; Schwager SC; Taufalele PV; Wang W; Mosier JA; Ortiz-Otero N; McArdle TJ; Goldblatt ZE; Lampi MC; Bordeleau F; Marshall JR; Richardson IM; Li J; King MR; Reinhart-King CA Cancer Res; 2021 Jul; 81(13):3649-3663. PubMed ID: 33975882 [TBL] [Abstract][Full Text] [Related]
34. Collagen XVII inhibits breast cancer cell proliferation and growth through deactivation of the AKT/mTOR signaling pathway. Lothong M; Sakares W; Rojsitthisak P; Tanikawa C; Matsuda K; Yodsurang V PLoS One; 2021; 16(7):e0255179. PubMed ID: 34293053 [TBL] [Abstract][Full Text] [Related]
35. Tumor Dormancy: Implications for Invasion and Metastasis. Gomatou G; Syrigos N; Vathiotis IA; Kotteas EA Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34064392 [TBL] [Abstract][Full Text] [Related]
36. Morphine promotes non-small cell lung cancer progression by downregulating E-cadherin via the PI3K/AKT/mTOR pathway. Gu F; Zhou Y; Tian L; Chen J; Zhang C; Huang Z; Yu W; Xie K Sci Rep; 2024 Sep; 14(1):21130. PubMed ID: 39256509 [TBL] [Abstract][Full Text] [Related]
37. Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy. Spiliotaki M; Mavroudis D; Kapranou K; Markomanolaki H; Kallergi G; Koinis F; Kalbakis K; Georgoulias V; Agelaki S Breast Cancer Res; 2014 Nov; 16(6):485. PubMed ID: 25432416 [TBL] [Abstract][Full Text] [Related]
38. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors. Smit DJ; Cayrefourcq L; Haider MT; Hinz N; Pantel K; Alix-Panabières C; Jücker M Cells; 2020 Sep; 9(9):. PubMed ID: 32962206 [TBL] [Abstract][Full Text] [Related]
39. Interplay between desmoglein2 and hypoxia controls metastasis in breast cancer. Chang PH; Chen MC; Tsai YP; Tan GYT; Hsu PH; Jeng YM; Tsai YF; Yang MH; Hwang-Verslues WW Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33431674 [TBL] [Abstract][Full Text] [Related]
40. Unveiling the Complex Ecosystem of Breast Cancer: Crucial Insights for Patients and Doctors. Mokbel K Anticancer Res; 2024 Aug; 44(8):3317-3319. PubMed ID: 39060063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]